Douglass Winthrop Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.4M | Buy |
61,088
+8,213
| +16% | +$1.77M | 0.27% | 45 |
|
|
2026
Q1 | $11.5M | Buy |
52,875
+182
| +0.3% | +$40.4K | 0.21% | 47 |
|
|
2025
Q4 | $12M | Buy |
52,693
+1,725
| +3% | +$393K | 0.21% | 49 |
|
|
2025
Q3 | $11.8M | Buy |
50,968
+9,022
| +22% | +$1.84M | 0.21% | 47 |
|
|
2025
Q2 | $7.79M | Hold |
41,946
| – | – | 0.14% | 59 |
|
|
2025
Q1 | $8.79M | Sell |
41,946
-272
| -0.6% | -$52.9K | 0.17% | 50 |
|
|
2024
Q4 | $7.5M | Sell |
42,218
-420
| -1% | -$77.2K | 0.15% | 58 |
|
|
2024
Q3 | $8.42M | Buy |
42,638
+1,274
| +3% | +$238K | 0.16% | 55 |
|
|
2024
Q2 | $7.09M | Sell |
41,364
-801
| -2% | -$133K | 0.14% | 62 |
|
|
2024
Q1 | $7.68M | Buy |
42,165
+1,043
| +3% | +$180K | 0.16% | 59 |
|
|
2023
Q4 | $6.37M | Buy |
41,122
+437
| +1% | +$63.7K | 0.14% | 62 |
|
|
2023
Q3 | $6.06M | Buy |
40,685
+822
| +2% | +$121K | 0.15% | 60 |
|
|
2023
Q2 | $5.37M | Sell |
39,863
-480
| -1% | -$70.4K | 0.13% | 64 |
|
|
2023
Q1 | $6.43M | Sell |
40,343
-2,026
| -5% | -$310K | 0.17% | 56 |
|
|
2022
Q4 | $6.85M | Sell |
42,369
-298
| -0.7% | -$45.7K | 0.19% | 51 |
|
|
2022
Q3 | $5.73M | Sell |
42,667
-750
| -2% | -$108K | 0.17% | 53 |
|
|
2022
Q2 | $6.65M | Buy |
43,417
+1,163
| +3% | +$178K | 0.19% | 49 |
|
|
2022
Q1 | $6.85M | Sell |
42,254
-2,254
| -5% | -$327K | 0.16% | 52 |
|
|
2021
Q4 | $6.03M | Sell |
44,508
-600
| -1% | -$70.9K | 0.14% | 63 |
|
|
2021
Q3 | $4.87M | Sell |
45,108
-1,925
| -4% | -$220K | 0.12% | 68 |
|
|
2021
Q2 | $5.3M | Sell |
47,033
-256
| -0.5% | -$28.8K | 0.13% | 62 |
|
|
2021
Q1 | $5.12M | Buy |
47,289
+7,028
| +17% | +$752K | 0.14% | 58 |
|
|
2020
Q4 | $4.31M | Sell |
40,261
-200
| -0.5% | -$19.2K | 0.12% | 60 |
|
|
2020
Q3 | $3.54M | Sell |
40,461
-2,147
| -5% | -$202K | 0.12% | 63 |
|
|
2020
Q2 | $4.18M | Buy |
42,608
+7,914
| +23% | +$697K | 0.16% | 57 |
|
|
2020
Q1 | $2.64M | Sell |
34,694
-1,338
| -4% | -$114K | 0.12% | 68 |
|
|
2019
Q4 | $3.19M | Sell |
36,032
-3,616
| -9% | -$300K | 0.11% | 75 |
|
|
2019
Q3 | $3M | Sell |
39,648
-3,464
| -8% | -$237K | 0.11% | 74 |
|
|
2019
Q2 | $3.13M | Sell |
43,112
-3,750
| -8% | -$295K | 0.13% | 75 |
|
|
2019
Q1 | $3.78M | Sell |
46,862
-1,033
| -2% | -$84.5K | 0.16% | 68 |
|
|
2018
Q4 | $4.42M | Sell |
47,895
-5,122
| -10% | -$450K | 0.22% | 60 |
|
|
2018
Q3 | $5.01M | Sell |
53,017
-13,383
| -20% | -$1.27M | 0.22% | 62 |
|
|
2018
Q2 | $6.15M | Buy |
66,400
+8,050
| +14% | +$786K | 0.28% | 63 |
|
|
2018
Q1 | $5.52M | Buy |
58,350
+8,169
| +16% | +$897K | 0.27% | 64 |
|
|
2017
Q4 | $4.85M | Buy |
50,181
+800
| +2% | +$75.4K | 0.26% | 59 |
|
|
2017
Q3 | $4.39M | Hold |
49,381
| – | – | 0.25% | 59 |
|
|
2017
Q2 | $3.58M | Sell |
49,381
-5,637
| -10% | -$379K | 0.22% | 61 |
|
|
2017
Q1 | $3.58M | Sell |
55,018
-3,050
| -5% | -$192K | 0.22% | 62 |
|
|
2016
Q4 | $3.64M | Buy |
58,068
+1,428
| +3% | +$87.2K | 0.25% | 60 |
|
|
2016
Q3 | $3.57M | Sell |
56,640
-4,851
| -8% | -$314K | 0.25% | 59 |
|
|
2016
Q2 | $3.81M | Sell |
61,491
-1,222
| -2% | -$74.5K | 0.27% | 61 |
|
|
2016
Q1 | $3.58M | Buy |
62,713
+139
| +0.2% | +$7.75K | 0.26% | 63 |
|
|
2015
Q4 | $3.71M | Sell |
62,574
-1,460
| -2% | -$84.1K | 0.27% | 65 |
|
|
2015
Q3 | $3.48M | Buy |
64,034
+5,686
| +10% | +$370K | 0.27% | 65 |
|
|
2015
Q2 | $3.42M | Hold |
58,348
| – | – | 0.27% | 64 |
|
|
2015
Q1 | $3.42M | Buy |
58,348
+45,600
| +358% | +$2.75M | 0.27% | 64 |
|
|
2014
Q4 | $834K | Buy |
12,748
+524
| +4% | +$33K | 0.07% | 108 |
|
|
2014
Q3 | $706K | Sell |
12,224
-100
| -0.8% | -$5.55K | 0.07% | 108 |
|
|
2014
Q2 | $696K | Buy |
12,324
+815
| +7% | +$42.8K | 0.06% | 104 |
|
|
2014
Q1 | $592K | Buy |
11,509
+4,937
| +75% | +$250K | 0.06% | 107 |
|
|
2013
Q4 | $347K | Buy |
6,572
+300
| +5% | +$14.7K | 0.04% | 140 |
|
|
2013
Q3 | $281K | Buy |
6,272
+500
| +9% | +$22.2K | 0.03% | 145 |
|
|
2013
Q2 | $239K | Buy |
+5,772
| New | +$252K | 0.03% | 153 |
|
Other funds holding ABBV
Douglass Winthrop Advisors's ABBV Position: Q2 2026 in Review
Douglass Winthrop Advisors increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $1.77M and bringing the position to 61,088 shares worth $15.4M. The position accounts for 0.27% of the portfolio, ranked #45.
Douglass Winthrop Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Douglass Winthrop Advisors held 61,088 shares of AbbVie worth $15.4M as of Q2 2026.
- Douglass Winthrop Advisors bought 8,213 AbbVie shares in Q2 2026, an estimated $1.77M.
- AbbVie made up 0.27% of Douglass Winthrop Advisors's portfolio in Q2 2026, its #45 holding.
- Douglass Winthrop Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Douglass Winthrop Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.